APA (7th ed.) Citation

Altman, A., Nelson, G. S., Ghatage, P., McIntyre, J. B., Capper, D., Chu, P., . . . Köbel, M. (2013). The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors. Modern pathology, 26(9), . https://doi.org/10.1038/modpathol.2013.55

Chicago Style (17th ed.) Citation

Altman, Alon, et al. "The Diagnostic Utility of TP53 and CDKN2A to Distinguish Ovarian High-grade Serous Carcinoma from Low-grade Serous Ovarian Tumors." Modern Pathology 26, no. 9 (2013). https://doi.org/10.1038/modpathol.2013.55.

MLA (9th ed.) Citation

Altman, Alon, et al. "The Diagnostic Utility of TP53 and CDKN2A to Distinguish Ovarian High-grade Serous Carcinoma from Low-grade Serous Ovarian Tumors." Modern Pathology, vol. 26, no. 9, 2013, https://doi.org/10.1038/modpathol.2013.55.